Profile data is unavailable for this security.
About the company
Shanghai Aopu Biotechnology Co Ltd is a China-based company mainly provides cell culture medium products and services. The Company's cell culture medium products are widely used in the manufacturing of protein, antibiotics, vaccine, cell therapy products, gene therapy products, and other biological products. The Company's contract development and manufacturing organization (CDMO) service platform provides comprehensive services covering antibody engineering humanized screening, cell strain cultivation, process development, pilot scale production, and clinical-stage sample production. The Company conducts businesses both in the domestic market and overseas markets.
- Revenue in CNY (TTM)254.91m
- Net income in CNY49.43m
- Incorporated2013
- Employees285.00
- LocationShanghai OPM Biosciences Co LtdBlock 28Lane 908, Ziping Road, Pudong New AeraSHANGHAI 201321ChinaCHN
- Phone+86 2 120780178
- Fax+86 2 168101069
- Websitehttp://www.opmbiosciences.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jiangsu Bioperfectus Technologies Co Ltd | 400.25m | -314.32m | 4.21bn | 684.00 | -- | 1.22 | -- | 10.52 | -5.36 | -5.36 | 6.83 | 58.77 | 0.0915 | 0.8592 | 1.57 | 585,153.50 | -7.19 | 25.41 | -8.36 | 31.26 | 63.20 | 63.37 | -78.53 | 32.86 | 6.05 | -- | 0.086 | 30.54 | -92.72 | 11.81 | -120.45 | -- | 2.43 | -- |
| Jinyao Pharmaceutical Co Ltd | 3.66bn | 107.59m | 4.32bn | 2.68k | 40.13 | 1.43 | -- | 1.18 | 0.0984 | 0.0984 | 3.35 | 2.76 | 0.5738 | 2.28 | 9.37 | 1,365,219.00 | 2.33 | 1.91 | 4.17 | 3.40 | 42.61 | 46.33 | 4.06 | 3.31 | 0.7584 | 27.18 | 0.2064 | 44.40 | 2.55 | 9.28 | 230.60 | -4.22 | -9.58 | 9.21 |
| Shanghai OPM Biosciences Co Ltd | 254.91m | 49.43m | 4.33bn | 285.00 | 87.82 | 2.01 | -- | 16.98 | 0.4294 | 0.4294 | 2.22 | 18.80 | 0.1095 | 2.07 | 2.54 | 894,431.90 | 2.09 | 4.34 | 2.16 | 4.65 | 58.86 | 58.31 | 19.06 | 23.40 | 19.91 | -- | 0.0315 | 45.38 | -17.41 | 48.34 | -48.72 | -- | 6.09 | -- |
| Assure Tech Hangzhou Co Ltd | 511.29m | 160.91m | 4.39bn | 791.00 | 27.31 | 0.8485 | -- | 8.60 | 1.27 | 1.27 | 4.02 | 40.75 | 0.0799 | 1.52 | 2.67 | 646,379.60 | 2.51 | 31.83 | 2.94 | 38.97 | 38.56 | 65.82 | 31.47 | 47.86 | 8.26 | -- | 0.0166 | 16.05 | -91.84 | 25.18 | -95.35 | 33.51 | 78.77 | -- |
| Yabao Pharmaceutical Group Co Ltd | 2.88bn | 204.43m | 4.41bn | 4.14k | 22.26 | 1.51 | -- | 1.53 | 0.2754 | 0.2754 | 3.81 | 4.05 | 0.7193 | 2.98 | 6.79 | 695,432.10 | 4.52 | 2.82 | 5.90 | 3.97 | 56.00 | 59.20 | 6.29 | 4.19 | 1.62 | 47.13 | 0.0675 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
| Shanghai Medicilon Inc | 1.17bn | -172.33m | 4.44bn | 2.60k | -- | 1.80 | -- | 3.78 | -1.24 | -1.24 | 9.11 | 18.34 | 0.4205 | 6.63 | 1.64 | 451,437.20 | -6.17 | 9.34 | -7.97 | 11.73 | 12.48 | 36.71 | -14.68 | 14.93 | 2.63 | -- | 0.1229 | 20.18 | -17.68 | 33.26 | -109.82 | -- | 23.60 | -- |
| Hainan Huluwa Pharmaceutical Grop Co Ltd | 1.81bn | 94.97m | 4.46bn | 2.47k | 46.93 | 3.88 | -- | 2.46 | 0.2374 | 0.2374 | 4.52 | 2.87 | 0.6721 | 2.88 | 3.81 | 732,708.90 | 3.80 | 5.81 | 6.29 | 9.78 | 50.33 | 58.01 | 5.66 | 7.03 | 0.8245 | 7.04 | 0.5246 | 21.74 | 25.75 | 14.13 | 24.29 | 1.16 | 46.37 | -- |
| Shanghai Haoyuan Chemexpress Co Ltd | 1.97bn | 97.97m | 4.53bn | 3.37k | 46.16 | 1.78 | -- | 2.30 | 0.652 | 0.652 | 13.10 | 16.92 | 0.4845 | 1.01 | 3.91 | 583,547.80 | 2.38 | 7.38 | 3.23 | 9.60 | 42.51 | 47.03 | 4.92 | 13.53 | 0.894 | 3.37 | 0.3013 | 14.37 | 38.44 | 44.33 | -34.18 | 47.24 | 48.95 | -- |
Data as of May 31 2024. Currency figures normalised to Shanghai OPM Biosciences Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
22.88%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Shenzhen Fortune Caizhi Venture Capital Management Co., Ltd.as of 09 May 2024 | 5.74m | 7.60% |
| China Merchants Fund Management Co., Ltd.as of 31 Dec 2023 | 2.75m | 3.64% |
| Huashang Fund Management Co., Ltd.as of 31 Dec 2023 | 1.60m | 2.12% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 1.39m | 1.84% |
| Golden Trust Sinopac Fund Management Co., Ltd.as of 31 Dec 2023 | 1.34m | 1.78% |
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 1.07m | 1.42% |
| HSBC Jintrust Fund Management Co. Ltd.as of 31 Dec 2023 | 1.07m | 1.41% |
| Baoying Fund Management Co., Ltd.as of 31 Dec 2023 | 1.06m | 1.40% |
| E Fund Management Co., Ltd.as of 31 Dec 2023 | 655.52k | 0.87% |
| Harvest Fund Management Co., Ltd.as of 31 Dec 2023 | 610.58k | 0.81% |
More ▼
Data from 31 Dec 2023 - 09 May 2024Source: FactSet Research Systems Inc.
